RT Journal Article
SR Electronic
T1 Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003272
DO 10.1136/jitc-2021-003272
VO 9
IS 10
A1 Slingluff, Craig L
A1 Lewis, Karl D
A1 Andtbacka, Robert
A1 Hyngstrom, John
A1 Milhem, Mohammed
A1 Markovic, Svetomir N
A1 Bowles, Tawnya
A1 Hamid, Omid
A1 Hernandez-Aya, Leonel
A1 Claveau, Joel
A1 Jang, Sekwon
A1 Philips, Prejesh
A1 Holtan, Shernan G
A1 Shaheen, Montaser F
A1 Curti, Brendan
A1 Schmidt, William
A1 Butler, Marcus O
A1 Paramo, Juan
A1 Lutzky, Jose
A1 Padmanabhan, Arvinda
A1 Thomas, Sajeve
A1 Milton, Daniel
A1 Pecora, Andrew
A1 Sato, Takami
A1 Hsueh, Eddy
A1 Badarinath, Suprith
A1 Keech, John
A1 Kalmadi, Sujith
A1 Kumar, Pallavi
A1 Weber, Robert
A1 Levine, Edward
A1 Berger, Adam
A1 Bar, Anna
A1 Beck, J Thaddeus
A1 Travers, Jeffrey B
A1 Mihalcioiu, Catalin
A1 Gastman, Brian
A1 Beitsch, Peter
A1 Rapisuwon, Suthee
A1 Glaspy, John
A1 McCarron, Edward C
A1 Gupta, Vinay
A1 Behl, Deepti
A1 Blumenstein, Brent
A1 Peterkin, Joanna J
YR 2021
UL http://jitc.bmj.com/content/9/10/e003272.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.